Delivery Order SPE2DB20D1100-SPE2DB24FB7D2

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $4,569.04 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a specialty medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for $1,580.64. The contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, under which Amerisourcebergen provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $1,483.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a $18,994.96 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a wide range of medical commodities and pharmaceutical products from Amerisourcebergen....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract, valued at $7,061.78, has an ultimate completion date of November 25, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,388.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 13, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a $1,289.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products, with a period of performance through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This $9,462.93 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This is a $1,143.87 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $7,076.79 and a performance period ending on May 14, 2024. Amerisourcebergen provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various federal agencies, with a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB7D2
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,392.48 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML medication. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 8/8/24, 10:25 AM